Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
CEA Pharm IVS
IVS
Dissolved
Reklamebeskyttelse
CVR 38463721
Folevænget 7, 2920
Charlottenlund
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2017 · 9 years old
— employees
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
CEA Pharm IVS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
Income statement
DKK thousands
Item
2017
2018
2019
2020
Gross profit
3
3
3
3
Staff expenses
-0
-0
-0
-0
EBITDA
-2
-3
-3
-3
Depreciation & amort.
-0
-0
-0
-0
EBIT
-2
-3
-3
-3
Net financials
0
0
0
0
Profit before tax
-2
-3
-3
-3
Tax
-0
-0
-0
-0
Net profit
-2
-3
-3
-3
Balance sheet
DKK thousands
Item
2017
2018
2019
2020
Total assets
5
5
5
5
Equity
3
-1
-4
-7
Long-term debt
0
0
0
0
Short-term debt
3
6
9
12
Total debt
3
6
9
12
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-100.0%
This company
2017
2020
Soliditetsgrad
-141.1%
This company
38.2%
Market median
-469% vs market
2017
2020
Egenkapitalforrentning
-330500.0%
This company
18.4%
Market median
-1796296% vs market
2017
2020
Nettoresultatgrad (af bruttofortjeneste)
-100.0%
This company
2017
2020
Aktivomsætning (af bruttofortjeneste)
0.66×
This company
2017
2020
Gæld/egenkapital
1.71×
This company
0.62×
Market median
-176% vs market
2017
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-03-06 – 2017-09-30
View
PDF
More on CEA Pharm IVS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network